Law360, New York (May 21, 2012, 8:20 PM ET) -- Despite early fears of a filibuster, the U.S. Senate agreed Monday to move forward with the U.S. Food and Drug Administration user fee bill and will begin considering amendments on Tuesday, including a controversial measure aimed at ending “pay for delay” agreements.
The Senate will begin debating proposed amendments Tuesday, and leaders said Monday that they hope to hold a final vote by the end of the week. Supporters from both parties urged their colleagues not to bog down the legislation with unrelated or controversial amendments....
Senate To Consider FDA User Fee Bill Amendments
To view the full article, take a free trial now.
